バイカリン市場：形態別、最終用途別-2024-2030年の世界予測

バイカリン市場規模は2023年に1億5,268万米ドルと推定され、2024年には1億5,771万米ドルに達し、CAGR 3.42%で2030年には1億9,334万米ドルに達すると予測されています。

バイカリンは、Scutellaria baicalensis Georgiの根から単離されたフラボン配糖体であり、伝統的な漢方薬に広く使用されている植物です。抗酸化作用、抗炎症作用、抗ウイルス作用、抗がん作用など多くの薬理作用を示します。その化学的意義は治療効果だけにとどまらず、紫外線による皮膚の損傷を緩和し、皮膚の健康を改善する能力から、化粧品、特にスキンケア製品への応用も視野に入れています。ハーブや自然療法への世界のシフトは、バイカリンを含む製品への需要を増幅させています。天然成分を求める急成長中の化粧品業界は、バイカリンを様々なスキンケア処方で顕著に使用し、バイカリン市場の成長基盤を作り出しています。世界の消費者の健康志向の高まりが、バイカリン配合製品への需要を促進しています。バイカリンの承認や販売に関する厳しい規制や、バイカリンの誤った服用や長期使用に伴う潜在的な副作用が市場成長の妨げとなっています。バイカリンの新たな健康効果を明らかにする継続的な研究開発活動は、市場の成長に貢献すると期待されています。

形態バイカリン粉末の利用が増加し、臨床および一般消費者の両方で一貫した投与と使いやすさが確保されています。

バイカリンエキスは、薬効で有名な植物であるオウゴン（Scutellaria baicalensis）の乾燥根から主に溶媒抽出によって得られます。この濃縮された形態は、植物の薬理学的効果の原因となる生理活性化合物バイカリンを保存します。エキスは、サプリメント、医薬品、化粧品に使用されることが多く、バイカリンの治療効果を強力にサポートします。バイカリンパウダーは、エキスをさらに精製、乾燥させ、細かい顆粒状に加工したものです。そのため、カプセル、錠剤、健康飲料、外用剤など、様々な製品への配合が容易になり、応用範囲が広がります。粉末状であるため、臨床現場でも消費者環境でも一貫した投与と使いやすさが保証され、バイカリンの完全性と有効性が維持されます。

最終用途バイカリンの抗酸化作用と抗炎症作用は、スキンケアと化粧品業界において高い可能性を秘めています。

バイカリンの最も顕著な用途は、抗炎症性、抗ウイルス性、抗酸化性、抗がん作用を持つ製薬業界です。バイカリンの呼吸器感染症、肝疾患、ある種のがんに対する有効性は、バイカリンを天然医薬品や代替医薬品の処方において重要な成分にしています。さらに、バイカリンの神経保護作用は、アルツハイマー病やパーキンソン病などの神経変性疾患の治療法開発の可能性を提供します。スキンケアと化粧品において、バイカリンは抗酸化作用と抗炎症作用があり、皮膚の保護と若返りに貢献します。肌の老化を抑え、紫外線ダメージから守り、ニキビや湿疹のような炎症性皮膚疾患の治療を目的とした製品によく見られます。クリーム、美容液、マスクに配合されることで、肌の健康と美しさを促進する価値が強調されます。バイカリンは栄養補助食品に配合され、健康増進に役立っています。バイカリンは、免疫機能を強化し、肝臓の健康を増進し、不安感を軽減する働きがあるため、総合的な健康を目的とした栄養補助食品に配合されます。さらに、バイカリンの血糖値管理や抗肥満効果の可能性が検討されており、代謝の健康に焦点を当てた栄養補助食品への応用が広がっています。

地域別インサイト

南北アメリカでは、伝統的な漢方薬によく使用されるオウゴン由来のバイカリンを含む天然ハーブサプリメントへの関心が高まっています。米国は、ヘルスケアのインフラが確立していること、ハーブ療法に対する意識が高まっていること、研究開発に従事する主要企業が存在することから、重要な市場となっています。アジア太平洋地域は、伝統的な漢方薬が深く根付いていることから、生産と消費の中心地となっています。この地域の主要国である中国は、抗炎症作用、抗ウイルス作用、抗酸化作用など、バイカリンの健康効果を謳い、長い間使用してきた歴史があります。中国におけるオウゴンの大規模な栽培と高度な抽出技術は、バイカリンの世界的供給に大きく貢献しています。日本や韓国のような国も、文化的受容と伝統的な漢方薬の影響により、市場で強い存在感を示しています。APAC市場は、天然物研究を支援する政府のイニシアティブと、国内外の需要に応える急成長中の天然サプリメント産業によってさらに強化されています。EMEA（欧州・中東・アフリカ）地域では、自然健康製品に対する消費者の関心が高まり、医薬品・栄養補助食品部門が発達していることから、バイカリン市場が立ち上がりつつあります。EUでは、ハーブ医薬品の安全性と有効性に焦点を当てた規制の枠組みが市場の拡大に影響を与えています。中東とアフリカは徐々に追い上げており、消費者の健康意識の高まりと代替・補完医薬品への関心の高まりが市場開拓に影響を与えています。EMEA地域内の多様な文化的受容はバイカリンの市場成長にとって肥沃な土壌となっているが、規制の違いや市場浸透に関する課題は依然として残っています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはバイカリン市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、バイカリン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.バイカリン市場の市場規模および予測は？

2.バイカリン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.バイカリン市場の技術動向と規制枠組みは？

4.バイカリン市場における主要ベンダーの市場シェアは？

5.バイカリン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中の消費者の健康意識の高まり
    • ハーブや自然療法の新たなトレンドは、その関連する利点によるものです
  • 抑制要因
    • 漢方薬の承認と販売に関する厳格な規制
  • 機会
    • バイカリンの応用を改善するための継続的な研究開発
    • 化粧品におけるバイカリンの高い可能性
  • 課題
    • バイカリンの不適切な投与量に関連する潜在的な副作用
• 市場セグメンテーション分析
  • 形態：臨床および消費者の両方の環境で一貫した投与量と使いやすさを保証するバイカリン粉末の使用が増加しています
  • 最終用途：抗酸化作用と抗炎症作用により、スキンケアおよび化粧品業界全体でバイカリンに大きな可能性
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 バイカリン市場：形態別

• 抽出する
• 粉

第7章 バイカリン市場：最終用途別

• 栄養補助食品および栄養補助食品
• 製薬
• スキンケア＆化粧品

第8章 南北アメリカのバイカリン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のバイカリン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイカリン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • メルク・インド、成長する製薬業界の恩恵を受けるためにインフラを拡大
  • アクセラレーテッド・アクセス・コラボレーティブ、脳卒中、心血管疾患、呼吸器疾患のイノベーションに1,100万ユーロの投資を発表
• 戦略分析と提言

第12章 競争力のあるポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BAICALIN MARKET RESEARCH PROCESS
• FIGURE 2. BAICALIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BAICALIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BAICALIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BAICALIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BAICALIN MARKET DYNAMICS
• FIGURE 7. GLOBAL BAICALIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BAICALIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BAICALIN MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BAICALIN MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS BAICALIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS BAICALIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES BAICALIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES BAICALIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC BAICALIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC BAICALIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. BAICALIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 20. BAICALIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BAICALIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BAICALIN MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BAICALIN MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BAICALIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BAICALIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BAICALIN MARKET SIZE, BY EXTRACT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BAICALIN MARKET SIZE, BY EXTRACT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BAICALIN MARKET SIZE, BY POWDER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BAICALIN MARKET SIZE, BY POWDER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BAICALIN MARKET SIZE, BY NUTRACEUTICALS & DIETARY SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BAICALIN MARKET SIZE, BY NUTRACEUTICALS & DIETARY SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BAICALIN MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BAICALIN MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BAICALIN MARKET SIZE, BY SKINCARE & COSMETICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BAICALIN MARKET SIZE, BY SKINCARE & COSMETICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. AMERICAS BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 22. AMERICAS BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 23. AMERICAS BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 24. AMERICAS BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 25. AMERICAS BAICALIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 26. AMERICAS BAICALIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 27. ARGENTINA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 28. ARGENTINA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 29. ARGENTINA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 30. ARGENTINA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 31. BRAZIL BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 32. BRAZIL BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 33. BRAZIL BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 34. BRAZIL BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 35. CANADA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 36. CANADA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 37. CANADA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 38. CANADA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 39. MEXICO BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 40. MEXICO BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 41. MEXICO BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 42. MEXICO BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 43. UNITED STATES BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 44. UNITED STATES BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 45. UNITED STATES BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 46. UNITED STATES BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 47. UNITED STATES BAICALIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 48. UNITED STATES BAICALIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 50. ASIA-PACIFIC BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 52. ASIA-PACIFIC BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BAICALIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BAICALIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 55. AUSTRALIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 56. AUSTRALIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 57. AUSTRALIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 58. AUSTRALIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 59. CHINA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 60. CHINA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 61. CHINA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 62. CHINA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 63. INDIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 64. INDIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 65. INDIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 66. INDIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 67. INDONESIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 68. INDONESIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 69. INDONESIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 70. INDONESIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 71. JAPAN BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 72. JAPAN BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 73. JAPAN BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 74. JAPAN BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 75. MALAYSIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 76. MALAYSIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 77. MALAYSIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 78. MALAYSIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 79. PHILIPPINES BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 80. PHILIPPINES BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 81. PHILIPPINES BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 82. PHILIPPINES BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 83. SINGAPORE BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 84. SINGAPORE BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 85. SINGAPORE BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 86. SINGAPORE BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 88. SOUTH KOREA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 90. SOUTH KOREA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 91. TAIWAN BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 92. TAIWAN BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 93. TAIWAN BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 94. TAIWAN BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 95. THAILAND BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 96. THAILAND BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 97. THAILAND BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 98. THAILAND BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 99. VIETNAM BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 100. VIETNAM BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 101. VIETNAM BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 102. VIETNAM BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BAICALIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 109. DENMARK BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 110. DENMARK BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 111. DENMARK BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 112. DENMARK BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 113. EGYPT BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 114. EGYPT BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 115. EGYPT BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 116. EGYPT BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 117. FINLAND BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 118. FINLAND BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 119. FINLAND BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 120. FINLAND BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 121. FRANCE BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 122. FRANCE BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 123. FRANCE BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 124. FRANCE BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 125. GERMANY BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 126. GERMANY BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 127. GERMANY BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 128. GERMANY BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 129. ISRAEL BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 130. ISRAEL BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 131. ISRAEL BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 132. ISRAEL BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 133. ITALY BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 134. ITALY BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 135. ITALY BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 136. ITALY BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 137. NETHERLANDS BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 138. NETHERLANDS BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 140. NETHERLANDS BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 141. NIGERIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 142. NIGERIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 143. NIGERIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 144. NIGERIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 145. NORWAY BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 146. NORWAY BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 147. NORWAY BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 148. NORWAY BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 149. POLAND BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 150. POLAND BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 151. POLAND BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 152. POLAND BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 153. QATAR BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 154. QATAR BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 155. QATAR BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 156. QATAR BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 157. RUSSIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 158. RUSSIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 159. RUSSIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 160. RUSSIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 162. SAUDI ARABIA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 164. SAUDI ARABIA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 166. SOUTH AFRICA BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH AFRICA BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 169. SPAIN BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 170. SPAIN BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 171. SPAIN BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 172. SPAIN BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 173. SWEDEN BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 174. SWEDEN BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 175. SWEDEN BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 176. SWEDEN BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 177. SWITZERLAND BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 178. SWITZERLAND BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 180. SWITZERLAND BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 181. TURKEY BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 182. TURKEY BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 183. TURKEY BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 184. TURKEY BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM BAICALIN MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
• TABLE 190. UNITED KINGDOM BAICALIN MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BAICALIN MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 192. UNITED KINGDOM BAICALIN MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 193. BAICALIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. BAICALIN MARKET, FPNV POSITIONING MATRIX, 2023

[190 Pages Report] The Baicalin Market size was estimated at USD 152.68 million in 2023 and expected to reach USD 157.71 million in 2024, at a CAGR 3.42% to reach USD 193.34 million by 2030.

Baicalin is a flavone glycoside isolated from the root of Scutellaria baicalensis Georgi, a plant widely used in traditional Chinese medicine. It exhibits a plethora of pharmacological effects, including antioxidant, anti-inflammatory, antiviral, and anticancer activities. Its chemical significance is not only confined to its therapeutic effects but also encompasses a role in cosmetic applications, particularly in skin-care products, due to its ability to mitigate skin damage caused by UV radiation and improve skin health. A global shift towards herbal and natural medicine has amplified the demand for products, including baicalin. The burgeoning cosmetic industry, seeking natural ingredients, prominently features baicalin in various skincare formulations, creating a platform for the growth of the baicalin market. Growing health consciousness among consumers worldwide fuels the demand for baicalin-enriched products. Stringent regulations concerning the approval and marketing of herbal medicines and potential side effects associated with incorrect doses or prolonged use of baicalin hamper the market growth. Continuous research & development activities unveiling new health benefits of baicalin are expected to contribute to the market growth.

Form: Rising usage of baicalin powder that ensures consistent dosing and ease of use in both clinical and consumer settings

Baicalin extract is primarily obtained through solvent extraction from the dried roots of Scutellaria baicalensis, a plant species renowned for its medicinal properties. This concentrated form preserves the bioactive compound baicalin, which is responsible for the plant's pharmacological benefits. Extracts are often used in the formulation of supplements, pharmaceuticals, and cosmetic products, offering a potent source of baicalin's therapeutic attributes. Baicalin powder is a processed form where the extract undergoes further refinement and drying to produce a fine, granulated substance. This enhances its versatility in application, allowing for easier integration into a wide range of products, including capsules, tablets, health beverages, and topical formulations. The powder form ensures consistent dosing and ease of use in both clinical and consumer settings, maintaining the integrity and efficacy of baicalin.

End-use: High potential for baicalin across the skincare & cosmetics industry for its antioxidant and anti-inflammatory attributes

Baicalin's most prominent application lies within the pharmaceutical industry, courtesy of its anti-inflammatory, antiviral, antioxidant, and anticancer properties. Its efficacy in treating respiratory infections, liver diseases, and certain types of cancers makes it a critical component in the formulation of natural and alternative medicines. Moreover, Baicalin's neuroprotective effects offer the potential to develop treatments for neurodegenerative disorders such as Alzheimer's and Parkinson's disease. In skincare & cosmetics, baicalin is utilized for its antioxidant and anti-inflammatory attributes, contributing to skin protection and rejuvenation. It is commonly found in products aimed at reducing skin aging, protecting against UV damage, and treating inflammatory skin conditions such as acne and eczema. Its incorporation into creams, serums, and masks underscores its value in promoting skin health and aesthetic appeal. Baicalin is integrated into nutritional supplements to leverage its health-promoting benefits. Its role in bolstering immune function, enhancing liver health, and reducing anxiety positions it as a beneficial additive in dietary supplements aimed at overall wellness. Furthermore, Baicalin's potential in managing blood sugar levels and its anti-obesity effects are being explored, broadening its application in nutraceutical products focused on metabolic health.

Regional Insights

The Americas exhibit a growing interest in natural and herbal supplements, which include baicalin, predominantly derived from the Scutellaria baicalensis plant commonly used in traditional Chinese medicine. The United States represents a significant market due to its well-established healthcare infrastructure, increasing awareness about herbal medicine, and the presence of key market players engaging in research and development activities. The Asia-Pacific region is the epicenter of baicalin production and consumption, owing much to its deep roots in traditional Chinese medicine. China, as the leading country in this region, has a long history of using baicalin for its purported health benefits, including its anti-inflammatory, antiviral, and antioxidant properties. The extensive cultivation of Scutellaria baicalensis in China, along with sophisticated extraction techniques, contributes significantly to the global supply of baicalin. Countries like Japan and South Korea also reflect a strong market presence, attributed to cultural acceptance and the influence of traditional herbal medicine. The APAC market is further bolstered by government initiatives supporting natural product research and a burgeoning natural supplement industry catering to both local and international demands. In the EMEA region, the market for baicalin is emerging, with Europe's increased consumer interest in natural health products and the presence of a well-developed pharmaceutical and nutraceutical sector. Regulatory frameworks in the European Union focusing on the safety and efficacy of herbal medicinal products influence the market's expansion. The Middle East and Africa are gradually catching up, with the market development being influenced by growing health awareness among consumers and an increasing interest in alternative and complementary medicines. The diverse cultural acceptance within the EMEA region provides a fertile ground for baicalin's market growth, albeit challenges related to regulatory variations and market penetration persist.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Baicalin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Baicalin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Baicalin Market, highlighting leading vendors and their innovative profiles. These include Changsha Botaniex Inc., FUJIFILM Wako Pure Chemical Corporation, Kshipra Biotech Private Limited, Merck KgaA, Nanjing NutriHerb BioTech Co.,Ltd, Shanghai PureOne Biotechnology Co., Ltd., Spectrum Chemical Mfg. Corp., Tai'an Zhonghui Plant Biochemical Co.,Ltd., Thermo Fisher Scientific, Inc., Wuhan ChemFaces Biochemical Co., Ltd., and Zhucheng Haotian Pharm Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Baicalin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Form
  • Extract
  • Powder

• End-use
  • Nutraceuticals & Dietary Supplements
  • Pharmaceutical
  • Skincare & Cosmetics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Baicalin Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Baicalin Market?

3. What are the technology trends and regulatory frameworks in the Baicalin Market?

4. What is the market share of the leading vendors in the Baicalin Market?

5. Which modes and strategic moves are suitable for entering the Baicalin Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing health consciousness among consumers worldwide
    • 5.1.1.2. Emerging trend of herbal and natural medicine due to their associated benifits
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulations concerning the approval and marketing of herbal medicines
  • 5.1.3. Opportunities
    • 5.1.3.1. Continuous research & development to improve the application of baicalin
    • 5.1.3.2. High potential of baicalin in cosmetic products
  • 5.1.4. Challenges
    • 5.1.4.1. Potential side effects associated with incorrect doses of baicalin
• 5.2. Market Segmentation Analysis
  • 5.2.1. Form: Rising usage of baicalin powder that ensures consistent dosing and ease of use in both clinical and consumer settings
  • 5.2.2. End-use: High potential for baicalin across the skincare & cosmetics industry for its antioxidant and anti-inflammatory attributes
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Baicalin Market, by Form

• 6.1. Introduction
• 6.2. Extract
• 6.3. Powder

7. Baicalin Market, by End-use

• 7.1. Introduction
• 7.2. Nutraceuticals & Dietary Supplements
• 7.3. Pharmaceutical
• 7.4. Skincare & Cosmetics

8. Americas Baicalin Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Baicalin Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Baicalin Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Merck India Expands Infrastructure to Capitalise on Growing Pharmaceutical Industry
  • 11.3.2. Accelerated Access Collaborative Announces EUR 11 Million Investment in Stroke, Cardiovascular Disease and Respiratory Innovations
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio